MedPath

Developing Metagenomic Approaches to Identify the Causes of Pediatric Infectious Diseases

Recruiting
Conditions
Infectious Disease
Registration Number
NCT04320810
Lead Sponsor
Children's Hospital of Fudan University
Brief Summary

Infectious diseases remain leading causes of mortality and morbidity in children. Rapid and accurate diagnosis of infectious diseases in children is important for developing an effective treatment and management strategy. However, the current diagnosis of infectious agents mainly depends on culture and molecular testing. Both of the methods either has long turnaround times or narrow detection range. Metagenome next generation sequencing (mNGS) has been applied to the diagnosis of central nervous system infection, lower respiratory tract infection and sepsis, which showed high positive rate, short turnaround time. However, there is currently no assessment of the diagnostic efficacy of mNGS in children infectious diseases. This study used the DNA extraction and library construction technology developed for children's low volume clinical samples to assess the sensitivity and specificity of mNGS in the diagnosis of infectious diseases, and the treatment outcome based on mNGS test results.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients are highly suspected of sepsis;
  • Patients are highly suspected of respiratory infections;
  • Patients are highly suspected of central nervous system infection;
  • Patients are highly suspected of fever of unknown origin
Exclusion Criteria
  • Congenital malformations;
  • Patients requiring surgical intervention;
  • Patients with skin barrier dysfunction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The specificity of metagenome next generation sequencing in the diagnosis of pediatric infectious diseaseFrom the date of first samples enrolled until the last samples detected, up to 3 years

Samples from patients, who is suspected to central nervous system infection, respiratory infection, bloodstream infection and other unknown infections, will be tested by mNGS and traditional methods simultaneously. The specificity value will be calculated by comparing the detecting results of mNGS and traditional detecting methods.

The sensitivity of metagenome next generation sequencing in the diagnosis of pediatric infectious diseaseFrom the date of first samples enrolled until the last samples detected, up to 3 years

Samples from patients, who is suspected to central nervous system infection, respiratory infection, bloodstream infection and other unknown infections, will be tested by mNGS and traditional methods simultaneously. The sensitivity value will be calculated by comparing the detecting results of mNGS and traditional detecting methods.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Children Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Wenhao Zhou, Doctor
Contact
(+86)021-64931003
zwhchfu@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.